Secondary Marketplace / Explore Private Companies / Colossal Biosciences IPO
Colossal Biosciences Colossal Biosciences IPO
$10.2B
Series C Valuation, Jan 2025
Register for Details
For more details on financing and valuation for Colossal Biosciences, register or login.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Sign in
Company Details
Colossal Biosciences is a biotechnology company with the mission to bring back into existence past animal species currently extinct. The company employs teams of researchers aiming to uncover methods of rebuilding DNA systems using CRISPR and genetic engineering to reawaken prehistoric life and biology. Colossal Biosciences was founded in 2021 by Ben Lamm, George Church, Kent Wakeford, and Peter Phillips and is headquartered in Dallas, TX.
Founded
2021
Forge Price 1
Price not yet available
Post-Money Valuation 3
$10.2B
Total Funding
$440.64MM
LFR Price per Share
$xx.xx
Last Funding Share Class
Series C

Learn More About Colossal Biosciences

To invest in Colossal Biosciences pre-IPO

Can you invest in Colossal Biosciences pre-IPO?

Colossal Biosciences is a privately held company and is not publicly traded, therefore investing in Colossal Biosciences pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Colossal Biosciences before it goes public?

You can seek to sell your shares in Colossal Biosciences while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Colossal Biosciences shares?

To determine the value of your Colossal Biosciences shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Colossal Biosciences shares. You can also learn more about how to sell your private shares before getting started.

Is Colossal Biosciences a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Colossal Biosciences potential IPO

Will Colossal Biosciences go IPO?

Colossal Biosciences has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2025.

What is Colossal Biosciences’ IPO price?

The Colossal Biosciences IPO price does not exist at this time, as Colossal Biosciences is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Colossal Biosciences register for Forge Markets, today.

When was Colossal Biosciences founded?

Colossal Biosciences was founded in 2021.

What is Colossal Biosciences funding to date?

Colossal Biosciences has raised $440.64MM to date.
Colossal Biosciences Major Investors
Jazz Venture Partners
Jeff Wilke
At One Ventures
Westriver Group
Westriver Capital
Peak 6
Breyer Capital
Us Innovative Technology Fund
TWG Global
United States Innovative Technology Fund
Winklevoss Capital
Builders Vc
Climate Capital
Capital Factory
Robert Nelsen
Charles Hoskins
Green Sands Equity
Animal Capital
Boost Vc
First Light Capital Group
Draper Associates
Tony Robbins
Liquid2 Ventures
Paris Hilton
Animoca Brands
Bold Capital Partners
Thomas Tull
Bold Capital
Jazz Ventures
Global Space Ventures
Untamed Planet
In-Q-Tel
Victor Vescovo
Bob Nelsen

Colossal Biosciences Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
01/15/2025 Series C $200MM $xx.xx $10.2B TWG Global
Price per Share
$xx.xx
Shares Outstanding
8,035,485
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
TWG Global
07/23/2024 Series B $162.6MM $xx.xx $1.02B Animal Capital, Animoca Brands, Bob Nelsen, Bold Capital, Breyer Capital, In-Q-Tel, Jazz Ventures, Peak 6, United States Innovative Technology Fund, Victor Vescovo, Westriver Group
Price per Share
$xx.xx
Shares Outstanding
37,001,627
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Animal Capital, Animoca Brands, Bob Nelsen, Bold Capital, Breyer Capital, In-Q-Tel, Jazz Ventures, Peak 6, United States Innovative Technology Fund, Victor Vescovo, Westriver Group
03/09/2022 Series A $60MM $xx.xx $256.49MM Animal Capital, Animoca Brands, At One Ventures, Bold Capital, Boost Vc, Breyer Capital, Builders Vc, Charles Hoskins, Draper Associates, First Light Capital Group, Green Sands Equity, Jazz Ventures, Paris Hilton, Robert Nelsen, Thomas Tull, Untamed Planet
Price per Share
$xx.xx
Shares Outstanding
42,185,193
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Animal Capital, Animoca Brands, At One Ventures, Bold Capital, Boost Vc, Breyer Capital, Builders Vc, Charles Hoskins, Draper Associates, First Light Capital Group, Green Sands Equity, Jazz Ventures, Paris Hilton, Robert Nelsen, Thomas Tull, Untamed Planet
06/01/2021 Series Seed-2 $9.67MM $xx.xx $137.83MM Animal Capital, At One Ventures, Bold Capital, Breyer Capital, Capital Factory, Climate Capital, Draper Associates, First Light Capital Group, Global Space Ventures, Jazz Ventures, Jeff Wilke, Liquid2 Ventures, Thomas Tull, Tony Robbins, Winklevoss Capital
Price per Share
$xx.xx
Shares Outstanding
8,000,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Animal Capital, At One Ventures, Bold Capital, Breyer Capital, Capital Factory, Climate Capital, Draper Associates, First Light Capital Group, Global Space Ventures, Jazz Ventures, Jeff Wilke, Liquid2 Ventures, Thomas Tull, Tony Robbins, Winklevoss Capital
06/01/2021 Series Seed-1 $8.36MM $xx.xx $137.83MM Animal Capital, At One Ventures, Bold Capital, Breyer Capital, Capital Factory, Climate Capital, Draper Associates, First Light Capital Group, Global Space Ventures, Jazz Ventures, Jeff Wilke, Liquid2 Ventures, Thomas Tull, Tony Robbins, Winklevoss Capital
Price per Share
$xx.xx
Shares Outstanding
49,000,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Animal Capital, At One Ventures, Bold Capital, Breyer Capital, Capital Factory, Climate Capital, Draper Associates, First Light Capital Group, Global Space Ventures, Jazz Ventures, Jeff Wilke, Liquid2 Ventures, Thomas Tull, Tony Robbins, Winklevoss Capital
Private Companies Exploring an IPO
Last Funding Round
Company Forge Price Forge Price Change 5 Last Closed Trade Share Class Post-Money Valuation Price per Share Amount Raised
CerebrasCerebras$40.08+0.68%$xx.xxSeries F-1$2.84B$xx.xx$85MM
CoreWeaveCoreWeave$1,200.00+4.36%$xx.xxSeries C$19B$xx.xx$1.15B
ChimeChime$26.50+6.6%$xx.xxSeries G$24.93B$xx.xx$1.1B
KlarnaKlarna$370.00-1.33%$xx.xxUnknown$6.7B$xx.xx--
Liquid DeathLiquid Death$9.49+0.21%$xx.xxSeries F-1$1.4B$xx.xx$67.61MM
CircleCircle$25.50+3.2%$xx.xxSeries F$8.05B$xx.xx$401MM
NetskopeNetskope$12.03+8.67%$xx.xxSeries H$7.5B$xx.xx$300MM
CohesityCohesity$15.66-2.12%$xx.xxSeries H-1$4.69B$xx.xx$27.5MM
TuroTuro$13.00+0.31%$xx.xxSeries E$1.24B$xx.xx$240.52MM
Hinge HealthHinge Health$31.00-22.11%$xx.xxSeries E$6.2B$xx.xx$400MM

Updated on: Jan 23, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.